Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: Agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells

被引:38
|
作者
Watt, Heather L. [2 ]
Kharmate, Geetanjali D. [1 ]
Kumar, Ujendra [1 ]
机构
[1] Univ British Columbia, Fac Pharmaceut Sci, Div Pharmacol & Toxicol, Vancouver, BC V6T 1W5, Canada
[2] McGill Univ, Royal Victoria Hosp, Dept Expt Med, Fac Med, Montreal, PQ H3A 1A1, Canada
关键词
Somatostatin; Somatostatin receptors; Epidermal growth factor; Epidermal growth factor receptors; Dimerization; Extracellular signal-regulated kinase; HORMONE-RELEASING HORMONE; ESTROGEN-RECEPTOR; PROGNOSTIC VALUE; ERBB RECEPTORS; MESSENGER-RNA; EGF RECEPTOR; SUBTYPE; FACTOR-I; EXPRESSION; PROTEIN;
D O I
10.1016/j.cellsig.2008.11.012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of somatostatin (SST) and epidermal growth factor (EGF) in breast cancer is undisputed: however, the molecular mechanisms underlying their antiproliferative or proliferative effects are not well understood. We initially confirmed that breast turnout tissues express all five somatostatin receptors (SSTR1-5) and four epidermal growth factor receptors (ErbB1-4). Subsequently, to gain insight into the function of SSTRs and ErbBs in oestrogen receptor (ER)-positive (MCF-7) or ER alpha-negative (MDA-MB-231) breast cancer cells, we defined SSTR1, SSTR5 and ErbB1 mRNA and protein expression in these two tumour cell lines. Consistent with previous studies showing SSTR1/SSTR5 heterodimerization and having seen cell-specific and ligand-selective alterations in receptor expression, we next elucidated whether SSTR1 and SSTR5 functionally interactwith ErbB1 using pbFRET analysis. We subsequently determined the effects of SST and EGF either alone, or in combination, on selected downstream signalling molecules such as erk1/2, p38 and JNK. Here, we showed that both SST and EGF influenced erk1/2 phosphorylation and that SST modulated the effects of EGF in a cell-specific manner. We also demonstrated agonist-, time and cell-dependent regulation of p38 phosphorylation. We further investigated modulation of Grb2, SOS, Shc, SH-PTP1 and SH-PTP2. ErbB1 adaptor proteins known to play a role in MAPK activation, Shc, Grb2 and SOS, changed in an agonist- and cell-specific manner whereas, SH-PTP1 and SH-PTP2, adaptor proteins reported to interact with SSTRs, translocated from the cytosol to membrane in a cell-specific manner following SST and/or EGF treatment. Although several previous studies have shown crosstalk between RTKs and GPCRs, there are no reports describing SSTR (GPCR) modulation of ErbBs (RTK) in breast cancer. To the best of our knowledge, this is the first report describing crosstalk/interactions between SSTRs and ErbBs. (c) 2008 Published by Elsevier Inc.
引用
收藏
页码:428 / 439
页数:12
相关论文
共 50 条
  • [31] Lipid raft localization of epidermal growth factor receptor alters matrix metalloproteinase-1 expression in SiHa cells via the MAPK/ERK signaling pathway
    Zhang, Zongfeng
    Wang, Lina
    Du, Juan
    Li, Yuanbo
    Yang, Huilun
    Li, Chenxi
    Li, Hui
    Hu, Haiyang
    ONCOLOGY LETTERS, 2016, 12 (06) : 4991 - 4998
  • [32] MODULATION OF ESTROGEN-RECEPTOR AND EPIDERMAL GROWTH-FACTOR RECEPTOR MESSENGER-RNAS BY PHORBOL ESTER IN MCF-7 BREAST-CANCER CELLS
    LEE, CSL
    KOGA, M
    SUTHERLAND, RL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 162 (01) : 415 - 421
  • [33] TIEG1 Inhibits Breast Cancer Invasion and Metastasis by Inhibition of Epidermal Growth Factor Receptor (EGFR) Transcription and the EGFR Signaling Pathway
    Jin, Wei
    Chen, Bo-bin
    Li, Ji-yu
    Zhu, Hua
    Huang, Mark
    Gu, Sheng-mei
    Wang, Qiao-qiao
    Chen, Jia-ying
    Yu, Sanjian
    Wu, Jiong
    Shao, Zhi-ming
    MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (01) : 50 - 63
  • [34] BIOL 126-Exogenous short-chain ceramide inhibits agonist-dependent translocation of neurotensin receptor-1 to structured membrane microdomains in metastatic breast cancer cells
    Heakal, Yasser
    Kester, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [35] Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells
    Tsonis, Anastasios I.
    Afratis, Nikolaos
    Gialeli, Chrisostomi
    Ellina, Maria-Ioanna
    Piperigkou, Zoi
    Skandalis, Spyridon S.
    Theocharis, Achilleas D.
    Tzanakakis, George N.
    Karamanos, Nikos K.
    FEBS JOURNAL, 2013, 280 (10) : 2248 - 2259
  • [36] Protein kinase Cα negatively regulates cell spreading and motility in MDA-MB-231 human breast cancer cells downstream of epidermal growth factor receptor
    Gauthier, ML
    Torretto, C
    Ly, J
    Francescutti, V
    O'Day, DH
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 307 (04) : 839 - 846
  • [37] Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
    Gialeli, Chrysostomi
    Tuysuz, Emre Can
    Staaf, Johan
    Guleed, Safia
    Paciorek, Veronika
    Morgelin, Matthias
    Papadakos, Konstantinos S.
    Blom, Anna M.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [38] A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells
    Recchia, Anna Grazia
    Musti, Anna Maria
    Lanzino, Marilena
    Panno, Maria Luisa
    Turano, Ermanna
    Zumpano, Rachele
    Belfiore, Antonino
    Ando, Sebastiano
    Maggiolini, Marcello
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (03): : 603 - 614
  • [39] Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
    Chrysostomi Gialeli
    Emre Can Tuysuz
    Johan Staaf
    Safia Guleed
    Veronika Paciorek
    Matthias Mörgelin
    Konstantinos S. Papadakos
    Anna M. Blom
    Journal of Experimental & Clinical Cancer Research, 40
  • [40] Normal breast tissue cells from breast cancer patients express epidermal growth factor receptor HER1-4protein concentrations characteristic for cancer cells.
    Olsen, D. A.
    Oestergaard, B.
    Bokmand, S.
    Jakobsen, E. H.
    Brandslund, I
    CANCER RESEARCH, 2009, 69 (02) : 220S - 220S